S. Feshtali

发表

Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)

E. Verdaasdonk, H. Grabsch, J. Monson, 2021, BJS open.

Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program.

B. Bonsing, H. Vasen, A. Inderson, 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.

J. Ijzermans, S. Buettner, M. Gaspersz, 2017, Journal of hepatology.

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training

E. D. Geijsen, E. Verdaasdonk, J. Plate, 2022, Insights into Imaging.

A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Outcome in Patients with Pancreatic Cancer.

B. G. Sibinga Mulder, A. Vahrmeijer, B. Bonsing, 2019, Ultrasound in medicine & biology.

MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer

B. Bonsing, H. Vasen, A. Inderson, 2020 .

High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers

H. Putter, R. Tollenaar, H. Morreau, 2018, Cancer Prevention Research.

Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort

H. Morreau, B. Bonsing, A. Inderson, 2023, United European gastroenterology journal.

Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer

B. G. Sibinga Mulder, H. Morreau, A. Vahrmeijer, 2016, Journal of Clinical Pathology.

Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers

B. G. Sibinga Mulder, H. Morreau, T. Potjer, 2018, European Journal of Human Genetics.

Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer

B. G. Sibinga Mulder, H. Morreau, A. Vahrmeijer, 2017, Journal of Clinical Pathology.

Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers

B. G. Sibinga Mulder, H. Morreau, T. Potjer, 2018, European Journal of Human Genetics.

Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting

E. D. Geijsen, E. Verdaasdonk, L. Kroese, 2023, Annals of Surgical Oncology.

Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases

A. L. Vahrmeijer, B. G. Sibinga Mulder, K. Visser, 2018, BMC Medical Imaging.

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial

J. D. de Groot, M. Polée, M. Besselink, 2023, BMC Cancer.

Skeletal muscle mass in patients with end-stage liver disease: Not only muscle size but especially muscle quality matters in relation to physical fitness.

B. van Hoek, M. Tushuizen, D. Bot, 2023, Clinical Nutrition ESPEN.

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.

J. Ijzermans, S. Buettner, M. Gaspersz, 2017, Journal of hepatology.

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

H. Helgadottir, F. Lalloo, M. Nielsen, 2023, European Journal of Human Genetics.